Statewide reporting of coronary artery surgery results: A view from California  by Harlan, Bradley J.
When I began planning this address 2 years ago, the
plan was for the California Coronary Artery Bypass
Graft Mortality Reporting Program (CCMRP) to
release results publicly in 1999. For many reasons the
release has been repeatedly postponed and has not yet
occurred. The impact of the release and the reaction to
the release was what I thought would bring maximum
timeliness to my address, but that was not to be.
The imminent release of statewide data for California,
the experience with projects in New York, Pennsyl-
vania, New Jersey, Northern New England, and
Minnesota, and the proliferation of other statewide 
projects have stimulated me to review the history of
these projects, assess where they are now, and look to
the future, with both predictions and recommendations.
I have tried to gain access to the information in the
statewide reports by using the Internet. I think the
Internet is the medium most used by our patients to find
out what we do and how well we do it, and this use will
continue to grow in the future. Therefore, it is important
to know the present state of Internet information. 
New York
The New York State Department of Health developed
the first physician-specific mortality reports ever pub-
lished when it initiated the Cardiac Surgery Reporting
System (CSRS) in 1991.2 This project has been the
Ihave been interested in data collection and analysis formany years. While at the Oregon Health Sciences
University in the 1970s I was stimulated in this area. In
Sacramento, in the early 1980s, our group began a thor-
ough system of data collection and analysis, hiring a
full-time data manager in 1983 and beginning the tran-
sition to the Society of Thoracic Surgeons (STS) data-
base in 1991. In the early years we had a crude system
of risk prediction. Each surgeon would assign a risk to
each of his patients preoperatively at the morning meet-
ing. We then analyzed the observed and predicted
results as a method of quality assessment, and we pub-
lished an article in 1987.1
The Western Thoracic Surgical Association has had a
long and proud record of supporting outcomes research
and reporting. This has been part of several presidential
addresses in the past. Members of this Association have
served and are serving in important capacities in the
STS database project. 
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most controversial and the most studied of any
statewide project.
Today, everyone wanting information about the results
of coronary artery bypass grafting (CABG) in New York,
at least as of 1996, can go to the New York Department of
Health Web site (www.health.state.ny.us) and click on
“Info for Consumers.” This will take them to a page
where they can click on “heart disease” and then access
3 reports on CABG, covering 5 years up to 1996,
including 90,130 patients. 
The collection of statewide data in New York regard-
ing hospital outcomes of cardiac surgery began in the
1970s under the auspices of the Cardiac Advisory
Committee, which reported to the state department of
health (Edward Hannan: personal communication).
During the 1980s large variations in hospital mortality
rates were observed. At the request of the then-commis-
sioner, Dr David Axelrod, a patient-level, risk-adjusted
data system was developed and pilot tested in 1988 for
use in 1989. There was broad participation of cardiac
surgeons in setting up this program. Of the 21 members
of the Cardiac Advisory Committee, 20 were physicians
and 9 were cardiac surgeons. Participation in the CSRS
was mandatory to keep a certificate of need.
A form was completed at discharge by hospital car-
diac surgery departments for every cardiac surgical
patient in New York, including demographic data, dates
of admission, surgery, and discharge, risk factors, com-
plications, discharge status, surgeon, and hospital.3 The
CSRS used mathematical prediction models for risk
adjustment, collecting data on clinical risk factors with
known prognostic importance, such as low ejection
fraction, left main coronary artery stenosis, unstable
angina, congestive heart failure, and chronic obstruc-
tive pulmonary disease. A multivariate logistic-regres-
sion risk-adjustment model was used.4
The initial plan was to publish the results in the liter-
ature, keeping the identity of the hospitals confidential.
An article published in the Journal of the American
Medical Association (JAMA) appeared in December
1990.3 This article stated that 3 of 28 hospitals had bet-
ter than expected mortality rates and 4 had worse than
expected. Subsequent site visits to the “worse than
expected” hospitals showed a high percentage of qual-
ity of care problems.
Dr Axelrod unilaterally decided to release the data to
the media, with the hospitals identified, and on
December 4, 1990, an article appeared in New York
Newsday5 entitled “Ranking Open-Heart Surgery: State
Study Lists Best Hospitals.” The story was widely cov-
ered by the print and broadcast media throughout the
state. The era of public reporting of outcomes of car-
diac surgery was born.
New York Newsday discovered that the state depart-
ment of health also had data on individual surgeon per-
formance. They asked for these data and were refused.
Newsday then sued the department of health under the
Freedom of Information Act. This was decided in favor
of Newsday by the state supreme court.
On December 18, 1991, New York Newsday published
the article,6 “Heart Surgeons Rated: State Reveals
Patient-Mortality Records.” This article stated, “For the
first time, the state Health Department has released, by
name, adjusted mortality rates for each of 140 New York
heart surgeons, a list that can be used to compare doctors’
performance.” The era of surgeon-specific public report-
ing of cardiac surgery outcomes was born. 
The Newsday article listed all cardiac surgeons who
did CABGs in 1989 and 1990 with their caseloads and
their risk-adjusted mortality rates. The risk-adjusted
mortality rates ranged from 0% to 21.7%. The article
emphasized the higher mortality of the group of sur-
geons who did fewer than 50 cases a year, with Dr
Hannan, the biostatistician of the report, stating that the
average adjusted mortality rate of doctors averaging
under 50 bypasses a year was 6.1%, nearly twice the
3.1% mortality rate of surgeons averaging more than 50
operations a year.
Many surgeons criticized the premise and methodol-
ogy of the report, criticisms that have sparked a lively
debate in the media and in the medical literature that
has continued to the present day. The Newsday article
stated that interviews with 20 cardiac surgeons from a
dozen medical centers indicated the vast majority of
surgeons were at odds with the report. The Newsday
article quoted Dr Frank Spencer as saying, “This sys-
tem may make a hell of a contribution if it proves valid
one day. But right now, any statistician would blow it
out of the water.” The article stated that several sur-
geons warned that some surgeons were turning down
difficult cases to protect their statistics. Thus, from the
start, a number of areas of controversy were defined:
the quality of data collection and analysis, the relation-
ship between surgeon volume and mortality, and the
effect on patient access to cardiac surgical care.
Consumer advocates hailed the data’s publication. The
New York Public Interest Research Group said, “It is a
great victory for health consumers. If the state collects
data and taxpayers pay for it, consumers should be able
to look at it. Patients deserve to have as much information
as they can when they make life-and-death decisions.”
The Center for Medical Consumers in Manhattan, said,
“It is another piece of information that can be helpful in
making a choice as to where to seek care.”
The Cardiac Advisory Committee voted over-
whelmingly to recommend to hospitals that they sub-
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mit data to the Department of Health in a fashion that
would make it impossible to identify specific physi-
cians (Edward Hannan: personal communication).
Following this recommendation, much discussion was
held between the department of health and the
Cardiac Advisory Committee and other physician
leaders. In 1992, it was agreed that data on operative
morality would be compiled for the most recent 3
years according to surgeon and would be attributed by
name only to surgeons who performed at least 200
operations in a single hospital during that 3-year peri-
od. Surgeons below this level would be lumped
together in the category “other.”
The Cardiac Advisory Committee took an active role
in initiating change in hospitals with higher than
expected mortality. Site visits were conducted, process-
es reviewed, and specific recommendations for change
were made. The surgical privileges for some low-vol-
ume surgeons were restricted by the hospitals and other
low-volume surgeons with poor results elected to stop
performing cardiac surgery. The public release of the
results stimulated surgeons to review their care of cer-
tain subsets of patients and make improvements. A
group in Albany7 found a high mortality in patients
with active ischemia and initiated changes such as pre-
operative insertion of intra-aortic balloon pumps and
better pharmacologic management. This resulted in a
dramatic drop in the mortality of these patients.
It is likely that some of the criticism of the data and
data analysis was reasonable. But it is also likely that
both the surgeons and the data collectors and analyz-
ers shared in this responsibility. Until the dramatic
events surrounding the public release of these data,
this project had a low level of importance for many
cardiac surgeons. This rapidly changed, sometimes to
the point where under-coding was replaced by over-
coding.2 The prevalence of some risk factors, such as
chronic obstructive pulmonary disease and unstable
angina, increased markedly. Eventually, because of
appropriate changes in definition, better data report-
ing, better auditing, and refinement of risk-adjustment
algorithms, the fit between expected and actual mor-
tality rates, which did not exist in 1989, became pre-
sent in 1992.8
By the middle of the 1990s, the argument was being
made that the CSRS had resulted in improvement in
results of CABG in New York. In a 1994 article, Hannan
and colleagues9 reported that from 1989 to 1992 there
was a 21% decrease in actual mortality and a 41%
decrease in risk-adjusted mortality. Hannan and col-
leagues8 published an article in 1995 arguing that the
elimination of low-volume surgeons was an important
contribution to this improvement.
These studies intensified the debate over the relation-
ship between volume and quality. A study of the
Veterans Administration system, published in 1996,10
concluded that a volume threshold related to quality
could not be found. In 1996, the Ad Hoc Committee on
Cardiac Surgery Credentialing of the STS concluded,11
“Until conclusive data become available that link vol-
ume to outcome, volume should not be used as a crite-
rion for credentialing of cardiac surgeons by hospitals,
managed care groups, or others. Instead, each surgeon
should be evaluated on his or her individual results.”
The contention that the New York report was an
important stimulus to quality improvement was debat-
ed by the publication of an article from Massachusetts
in 1997,12 showing a 42% decline in risk-adjusted mor-
tality in Massachusetts from 1990 to 1994, where there
was no statewide public reporting of CABG results.
The highly publicized events occurring in New York,
and the possibility that public reporting would come to
Massachusetts, may have stimulated changes in
Massachusetts that otherwise would not have occurred.
By 1995, at least the New York Times was convinced
that the CSRS was improving results in New York. In
June of 1995, the Times published an article13 with the
headline, “Heart Bypasses Are Safer, Study Shows.” In
September of 1995, the Times published an editorial14
entitled, “Rating the Surgeons,” which stated, “New
York State’s annual report card for cardiac surgeons is
clearly having beneficial effects.”
In 1992 the issue of access for high-risk patients was
given major coverage when an article appeared in the
New York Times,15 entitled, “Faint Hearts.” As fate
would have it, a woman was turned down for surgery
because she had a fresh, large myocardial infarction.
Her daughter was a reporter for the New York Times.
After great difficulty, the daughter eventually found a
surgeon who would operate on her mother. The
reporter concluded her article with the statement, “My
mother beat the odds.”
The controversy over access heightened in 1996 with
the publication of an article from the Cleveland
Clinic16 analyzing their referrals for CABG from New
York State between 1989 and 1993. The Cleveland
Clinic found that their patients from New York had a
higher percentage of reoperations, more severe symp-
toms, and a higher mortality than patients from Ohio,
other states, and other countries. They concluded that
public dissemination of outcome data may have been
associated with increased referral of high-risk patients
from New York to the Cleveland Clinic. 
The Cleveland Clinic study has problems. These
investigators chose the period of analysis to begin in
January of 1989, although the first public release of
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data for New York hospitals did not occur until
December of 1990, and the public release of surgeon-
specific data, which should have been more likely to
increase surgeons’ unwillingness to operate on high-
risk patients, did not occur until December of 1991.
Thus, the increase in referrals to the Cleveland Clinic
began well in advance of the public release of data in
New York. Also, the increase in referrals was relatively
modest, rising from an average of 61 patients a year to
96 patients a year. These 35 extra patients, in the year
1992, represented only 0.2% of the 16,000 patients
undergoing CABG in New York that year.
Another article on the subject of access appeared in
1998, from the Duke Clinical Research Institute.17
These investigators examined national Medicare data
and found that the proportion of New Yorkers receiving
CABG outside of New York actually declined from
1987 to 1992, that the risk profile increased, and that
risk-adjusted mortality declined more in New York than
in the nation as a whole. 
Thus, New York set the stage for publicly released
CABG results, defined the areas of controversy, pro-
foundly affected the careers of some surgeons, and, as
we shall see, affected the way similar projects evolved
in other states
Pennsylvania
Finding online the publicly released statewide results
of CABG in Pennsylvania is much harder than finding
those of New York. The Pennsylvania Department of
Health Web site (www.health.state.pa.us) provides no
link. A search on Yahoo (www.yahoo.com) for
“Pennsylvania coronary artery surgery” yields nothing
relevant to the statewide project. I called the
Pennsylvania Department of Health and learned that
the project is under the auspices of the Pennsylvania
Health Care Cost Containment Council and posted on
its Web site (www.phc4.org). Pennsylvania’s Guide to
Coronary Artery Bypass Graft Surgery was last
released in May of 1998, covering 1994 to 1995.
The Pennsylvania project began in the late 1980s
(David B. Campbell: personal communication).
Participation was mandatory. The goals (Table I)
reflected the desire to provide large purchasers of
health care, as well as individual patients, with infor-
mation they could use in making health care decisions
based on quality and value. 
The committee setting up the project initially did not
include a single cardiac surgeon (David B. Campbell:
personal communication). After continuing pressure,
only one cardiac surgeon was asked to join. The first
report was released publicly in 1992, covering the year
1990. The latest report covers 1994 to 1995 and
includes 38,577 patients, 43 hospitals, and 189 sur-
geons. It gives risk-adjusted mortality for hospitals,
surgeons, and health plans. It is the only statewide 
project that assesses large health care purchasers.
Results are given as ranges of expected mortality and
outliers are indicated. Ninety-one percent of hospitals,
90% of surgeons, and 97% of health plans had risk-
adjusted mortality within the expected range.
The Pennsylvania project is now in limbo. Data are
not being harvested and no target date has been set for
the release of the next report. It is entirely possible that
the Pennsylvania project will not continue, as the
Pennsylvania Health Care Cost Containment Council
turns its interest to measuring quality related to large
health care purchasers (David B. Campbell: personal
communication).
New Jersey
The New Jersey statewide public reporting of CABG
results can be found online by going to the State of New
Jersey Department of Health and Senior Services Web
site (www.state.nj.us/health). A moderately difficult path
from here leads to “Cardiac Surgery in New Jersey 1998”
(www.state.nj.us/health/hcsa/cabgs99/consumer.htm),
released in May of 2000. This report covers only the year
1998.
In 1998 the New Jersey Department of Health adopted
regulations requiring hospitals to assure that each of its
cardiac surgeons perform a minimum of 100 procedures
a year at that hospital by the year 2001. New cardiac sur-
geons will have 3 years to reach this level (Emmanuel
Noggoh: personal communication). To my knowledge,
these will be the first minimum volume criteria applied to
any type of surgeon anywhere in the nation.
The New Jersey project began in the early 1990s. The
model used by New Jersey has evolved over the years,
stimulated by a data quality improvement group estab-
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Table I. Goals of Pennsylvania CABG Project
1. Provide an increasingly comprehensive picture of the system of health care
2. Provide purchasers with information that they can use to obtain greater value for the health care dollar
3. Provide hospitals, surgeons, and health plans with meaningful comparative data about CABG patients and the outcomes of bypass surgery
4. Provide patients who are considering CABG surgery, and their families, with data that will help them have more informed discussions with their physicians.
lished in 1997, including additional cardiac surgeons
(Alfred Casale: personal communication). During this
time the definitions evolved to those of the STS and the
report released this year has the same definitions as the
STS, but on slightly different forms. Participation is
mandatory.
The report released in 1999, covering 1996 to 1997,
had both hospital and surgeon-specific data. The report
released this year, covering 1998, including 8377
patients, contains only hospital data. The data are pre-
sented as risk-adjusted mortality with expected ranges,
and it is noted whether a hospital is better or worse than
the expected range. For 1998, for the 14 hospitals, 2 were
better than expected and 2 were worse than expected.
California
The California Coronary Artery Bypass Graft
Mortality Reporting Program (CCMRP) began in
1995. Information about this project is easy to find
online. This project differs from those in New York,
Pennsylvania, and New Jersey in three important
respects: (1) It is voluntary. (2) It does not collect sur-
geon-specific data. (3) There is a parallel project of
data collection and analysis using STS data. 
CCMRP is a cooperative venture between a state agency,
the Office of Statewide Health Planning and Development
(OSHPD) (Web site: www.oshpd.state.ca.us), which is
involved in health facility construction and financing,
health manpower, quality of health care, and access to
health care, and a private organization, the Pacific
Business Group on Health (PBGH) (Web site:
www.pbgh.org). PBGH is a business health coalition of
32 large purchasers representing more than 3 million
employees, dependents, and retirees with $3.5 billion in
annual health care expenditures. Members of PBGH
include Bank of America, Transamerica Corp, Atlantic
Richfield, Lockheed, Pacific Telesis Group, Charles
Schwab, GTE, as well as the University of California and
Stanford University. PBGH has been active for the past
decade in the assessment of health care quality, studying
the rates of cesarean sections in the early 1990s. Their
Web site for reports, www.healthscope.org, lists 39 dif-
ferent report cards for hospitals, health maintenance orga-
nizations, and medical groups. 
The goals of CCMRP were similar to the goals of the
other statewide programs (Table II). To participate,
hospitals agreed to submit to periodic audits and allow
the results to be publicly released. A technical adviso-
ry panel was chosen, consisting of 11 physicians (Table
III), 6 of whom are cardiac surgeons. These individuals
have worked long and hard to assure the quality of this
project, and every cardiac surgeon in California owes
them a large debt of gratitude.
Among the objectives of the project was to have a
short time elapse between data collection and publishing
of final reports, which has not been achieved, and to con-
struct a risk-adjustment model that accurately predicts
risk for high-risk patients, which I think has been
achieved. Under the direction of the statistician, Robert
Chung, a very diligent and conscientious individual, a
new logistic regression model was constructed, building
on the information on this subject published in the liter-
ature.18 Dr Hannan served as an early consultant to this
project (Robert Chung: personal communication).
PBGH and OSHPD carefully studied the New York and
Pennsylvania projects and were well informed about the
controversies concerning these projects.
PBGH and OSHPD could not use the STS software
and methods because the data collection software, risk-
adjustment algorithms, and surgical results were propri-
etary and confidential. Surgeon-specific data were not
collected because it was believed that analysis of these
data is difficult because of low numbers. Also, PBGH and
OSHPD believed that focusing on the hospital results
emphasized the reality that outcome of CABG surgery
reflects a team contribution, not simply the performance
of a single individual. They also thought not having sur-
geon-specific data would remove some of the controver-
sy that resulted from the other statewide projects and
would encourage participation in this voluntary program.
We still await the public release of data giving
results. The only data available now relate to volume
of CABG cases by hospital (www.healthscope.org).
These volume figures are available for 1997.
Hospitals that have declined to participate in the
CCMRP are indicated. Forty of the 120 hospitals in
California performing CABGs have declined to par-
ticipate. Three of the 10 highest-volume hospitals
declined to participate.
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Table II. Goals of CCMRP
To provide comparative risk-adjusted mortality rates to:
Hospitals and providers—to stimulate and facilitate review of surgical procedures and processes of care that will lead to improved outcomes
Purchasers of care—to assess hospital performance and incorporate quality measures into purchasing decisions
Patients and their family members—to enable them to make more informed treatment decisions
The third unique feature of the California project is
that there is a parallel data project, initiated under the
leadership of Joe Carey in 1995, when the California
Society of Thoracic Surgeons (CASTS) was formed.
The CASTS uses the STS database. This project
involves approximately 45 hospitals compared with the
80 in the CCMRP. The Duke Clinical Research
Institute has analyzed the CASTS data by hospital,
rather than the usual STS method of individual or
group. The CASTS results are yet to be released. It will
be interesting to compare the CCMRP data with the
CASTS data when they are released. 
Confidential statewide and regional projects
In addition to the 4 statewide projects that release
data publicly, there are statewide or regional projects
that do not release data publicly. There are also confi-
dential projects in the works.
The Northern New England Cardiovascular Disease
Study Group began in 1987 and first reported their blind-
ed results in JAMA in 1991.19 The study involved all car-
diac surgeons in Maine, New Hampshire, and Vermont.
The crude in-hospital mortality for isolated CABGs var-
ied from 3.1% to 6.3% among centers and from 1.9% to
8.2% among surgeons—statistically significant variabili-
ty. The group published a follow-up article in 1996,20
after having instituted a program of quality improvement
involving training in continuous quality improvement
techniques and site visits. This study group found a sta-
tistically significant 24% reduction in hospital mortality.
In 1993 the Minnesota Society of Thoracic Surgeons
and the Minnesota Cardiac Surgery Database were
organized under the leadership of Kit Arom and subse-
quently grew to an organization involving 46 cardiac
surgeons and 14 institutions.21 The data are analyzed
with the use of the STS format and definitions. A qual-
ity improvement program has been established involv-
ing exchange of practice guidelines, promotion of stan-
dardization, and exchange site visits.
The Minnesota program will be incorporated into a
4-state study of quality assessment and quality
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Table III. California CABG Mortality Reporting Program (CCMRP) Technical Advisory Panel
Chair
Robert Brook, MD, ScD
Director, Health Program, RAND 
Professor of Medicine and Public Health
UCLA Center for Health Sciences
Los Angeles, Calif
Members
Melvin D. Cheitlin, MD
Former Chief, Division of Cardiology
San Francisco General Hospital
Emeritus Professor of Medicine
University of California at San Francisco
San Francisco, Calif
Norman S. Kato, MD
Director, Cardiac Surgery
West Hills Medical Center
West Hills, Calif
Timothy A. Denton, MD
Attending Cardiologist
Director, Cardiothoracic Surgery Database
Cedars-Sinai Medical Center
Los Angeles, Calif
Siavosh Khonsari, MD
Chief, Regional Department of Cardiac Surgery
Kaiser Permanente, Southern California
Los Angeles, Calif
Pamela Hymel, MD
Director, Medical Services and Benefits
Hughes Electronics
Los Angeles, Calif
Jack Matlof, MD
Consultant and former Chief, Cardiothoracic Surgery
Cedars-Sinai Medical Center
Los Angeles, Calif
Leigh Iverson, MD
President, California Chapter of The Society of Thoracic Surgeons
Cardiac Surgeon, Summit Medical Center
Oakland, Calif
Jerry Royer, MD
Commissioner, CA Health Policy and Data
Advisory Commission
Sacramento, Calif
Forrest Junod, MD
Chief, Cardiothoracic Surgery
Sutter Memorial Hospital
Associate Clinical Professor of Surgery
University of California, Davis
Sacramento, Calif
Daniel J. Ullyot, MD
Director, Cardiac Surgery
Peninsula Mills Hospital
Burlingame, Calif
improvement programs, also including Colorado, Iowa,
and Alabama (T. Bruce Ferguson: personal communi-
cation). This study is the result of a 3-year, $1.5 million
dollar grant from the Agency for Healthcare Research
and Quality, with T. Bruce Ferguson and Frederick
Grover as principal investigators. They propose to
demonstrate that a continuous quality improvement
program can be successfully implemented on a nation-
al level using voluntary data collection. 
Other statewide projects are evolving in Washington
(Richard Goss: personal communication), Michigan
(Richard Prager: personal communication), and
Massachusetts (David Shahian: personal communica-
tion). These projects plan to evolve from quality assess-
ment to quality improvement.
Effects 
What have been the effects of the New York and
Pennsylvania projects on hospitals, cardiologists, sur-
geons, large purchasers of health care, and patients?
Hospitals have clearly responded to these studies. A
study of Pennsylvania hospitals showed 77% set up
administrative mechanisms to monitor quality and 38%
devoted a larger share of their financial resources to
improve quality.22 However, these studies do not seem
to have had any effect on market share. A study of New
York, published in the New England Journal of
Medicine in 1996,4 showed there was no change in the
percentage of patients in the highest and lowest mor-
tality hospitals between 1989 and 1993.
The impact of these reports on cardiologists is mini-
mal. Hannan and colleagues23 surveyed New York car-
diologists and got a very poor 36% response rate. Of
these, only 22% routinely discussed the report with
their patients and only 38% said the information affect-
ed their referral to surgeons “very much” or “some-
what.” Schneider and Epstein24 surveyed Pennsylvania
cardiologists, with a much better 64% response rate,
and similarly found that only 10% believed mortality
rates, as outlined in the guide, were “very important” in
assessing the performance of a cardiac surgeon.
Eighty-three percent reported the guide had little or no
effect on their referral patterns.
I have already discussed the effect the New York pro-
gram had on some low-volume surgeons. In 1999
Burack and colleagues25 published a survey of New
York cardiac surgeons, with a 69% response rate, and
found most did not experience a change in practice.
Despite all the efforts to improve reporting, approxi-
mately half picked the wrong definition of chronic
obstructive pulmonary disease or the wrong statistical
method. Almost two thirds refused to operate on at
least one high-risk patient over the previous year.
The effects of statewide reporting on large purchasers
are unclear. Pennsylvania found no difference in quality
among health plans. A recent article in JAMA, by
Erickson and colleagues,26 concluded that patients in
New York State with private managed care and Medicare
managed care insurance were significantly less likely to
use lower-mortality hospitals for CABG surgery than
patients with private fee-for-service insurance. This
report stimulated considerable comment in the media,
with an article in the New York Times27 entitled, “Those
in Managed Care Have Cardiac Surgery at Higher-Risk
Hospitals, Study Says,” and an article in the Wall Street
Journal28 entitled, “Heart Patients in Managed-Care
Plans in New York May Go to Lesser Hospitals.”
What about the ultimate effects, the most important
effects, those on patients? I think that statewide
reporting, at least in New York, has clearly improved
the quality of patient care and the outcomes of
CABG. But what about the goal of educating patients
and thereby making them wiser and more effective
consumers? I think the evidence for that, at least so
far, does not exist. Schneider and Epstein29 surveyed
a large group of patients in Pennsylvania who had
undergone CABG. Only 12% were aware of the
Consumer Guide before surgery and only 1.5%
reported knowing the rating of their surgeon. This
may have been caused by poor dissemination of the
report, since I have mentioned how hard it is to find
the report online. It remains to be seen whether more
effective use of the Internet will improve our patients’
knowledge about our results.
Forces of the future
What are the forces of the future? I think they can be
listed under two broad categories: consumerism and
the Internet. 
The forces of consumerism will not abate. The public
wants more information about health care and public
officials will continue to respond to this desire. Large
purchasers will continue to demand evidence that they
are getting value for their dollar. And, in an ironic twist
for purchasers, the public will demand to know that their
insurance companies and health maintenance organiza-
tions are interested in quality and not just price.
The Internet will continue to transform health care as
it transforms so much else in our lives. It will make
access to information regarding outcomes far easier
than it has ever been in the past, and a resourceful pub-
lic will continue to use the Internet to inform itself. We
already see this increasingly in our practices, as
patients are far better informed than in the past.
These forces will increase the demand for health out-
comes information in the future.
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Goals
What should be our goals for statewide projects? I
think these are the goals we should work toward:
Universal participation 
Universal use of the STS database
Simplification
Universal public release of data
Coordinated quality improvement
Universal participation is important to achieve the
other goals. It is admirable that the voluntary programs
in Northern New England and Minnesota have 100%
participation. The 67% institution participation in
California must be improved. 
We should work toward universal use of the STS
database. It is the largest and best database, now con-
taining more than 800,000 cases of isolated CABG.30
The Duke Clinical Research Institute, which manages
the database, is probably the premier institute of its
kind in the country. I believe that if the STS database
had been available for use in California by PBGH and
OSHPD in 1995, it would have been used. I believe it
will be possible to persuade the powers that be in
California to evolve toward use of the STS database in
the future. The New Jersey program is evolving
toward the STS. In New York, it will take considerable
work, probably involving an increase in auditing of
the STS database, but I think it is possible that the
New York program could eventually adopt the STS
database. Universal use of the STS database would
provide a single national standard, encourage partici-
pation by surgeons and institutions because it is the
most trusted, and create important cost saving by
avoiding duplication.
Data collection and analysis should be simplified and
made less expensive. Increased use of technology such
as wireless devices and the Internet should make collec-
tion and transmission of data easier and more cost-effec-
tive. Lowering the cost of these projects would be an
important factor in encouraging universal participation.
We should move toward universal public release of
data. Making our information public enhances our
credibility and, thereby, the trust of the public, health
care purchasers, state health officials, and politicians.
In an age when the public has access to statistics from
airlines about delayed flights and lost luggage, they
should have access to information about the quality of
heart surgery.
The very availability of information about results
stimulates quality improvement, but we should contin-
ue to expand our efforts in this area and learn from the
experience in Northern New England, Minnesota, and
the quality improvement projects of the STS. 
We can be proud of what our specialty has accom-
plished in the past decade in this relatively new and
exploding area of outcomes analysis and reporting. By
continuing our hard work and broad involvement, we
can help it evolve in a way that will benefit those we
care the most about—our patients. 
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